Miscellaneous ePI Test, published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cander2/epi-test/ and changes regularly. See the Directory of published versions
Generated Narrative: RegulatedAuthorization
Resource RegulatedAuthorization "authcarbamazepine200"
Profile: RegulatedAuthorization (ePI)
identifier: https://pmda-approvalandlicenseno/
/22700AMX00173 (use: official)
subject: MedicinalProductDefinition/medprodcarbamazepine200
type: Marketing Authorisation (#/#100000072062)
region: Japan (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#jp)
status: Active (PublicationStatus#active)
statusDate: 2002-08-01 13:28:17+0000
holder: Organization/orgfujinaga "Fujinaga Pharmaceutical Co., Ltd."